Duncan has more 30 years of practical experience in a wide range of biological disciplines particularly at the interface between biology, physics and engineering.
He is currently the CTO of Pelliscare Ltd, with patented technology to heal non-responsive chronic wounds such as diabetic foot ulcers (DFU).
He was the CSO at Vantix formerly Universal Sensors for 15 years. Duncan was the main inventor of the biosensor technology that was being developed for the decentralised POC market.
Duncan was a senior technology consultant at Scientific Generics (Sagentia), where he was central to a number of research and development projects. He has patents ranging from teabag innovation and commercial cappucino delivery in vending systems, to dielctrophoresis, electrical DNA denaturation and electrochemical biosensors as well as fluoropolymer chemistry for downstream processing and a medical formulation for healing chronic wounds.
Duncan was a research assistant for Dr C. R. Lowe, Institute of Biotechnology, Cambridge University where he worked on a variety of biosensing technologies and also gained a Ph.D for the development of a novel fluorocarbon support for affinity chromatography. Prior to that, Duncan was a research assistant at Royal Holloway and Bedford New College investigating the evolution of insulin-like molecules from small aqueous invertebrates to fish and land based vertebrates.